CLINICAL_TRIALS
trial_result
· 2025-12-02
Clinical Trial Update: GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA [Phase 3]
Summary
Phase 3 trial comparing golimumab plus methotrexate against methotrexate alone in very early psoriatic arthritis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Leeds Teaching Hospitals NHS Trust | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2025-12-02